Advancing Oncology Workflows Through End-to-End Automation

Automation is reshaping oncology genomics by enabling higher precision, reproducibility, and scalability across research workflows. This session will highlight how integrated automation in next generation sequencing (NGS) is advancing cancer genomics research and streamlining complex multi assay processes.
Pillar Biosciences will introduce a targeted NGS assay to support oncology research through accurate and consistent variant detection across various tumor types, followed by Clear Labs demonstrating the integration of tNGS assay into the Clear Dx™ automated platform, an adaptable end-to-end solution, simplifying oncology research workflows today and supports additional assays and panels in the future.
Finally, OneOncology will share real world findings from research samples processed using this automated workflow. Together, these presentations illustrate how automation is accelerating innovation and scalability in cancer genomics research.